Human factor VIII for bleeding in patients with inhibitors.
Kasper
C K
CK
Orthopaedic Hospital, University of Southern California, Los Angeles, Calif., USA.
D005169:Factor VIII / Q000008:administration & dosage* / Q000276:immunology; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy; D006470:Hemorrhage / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007518:Isoantibodies / Q000097:blood / Q000187:drug effects; D017410:Practice Guidelines as Topic
D007518:Isoantibodies; D005169:Factor VIII